Becton, Dickinson and Company announced some preliminary fiscal Q4 results recently. Read why I am reaffirming my prior buy ...

Becton Dickinson ( ($BDX) ) has issued an announcement. On October 15, 2025, BD announced a CFO transition plan as Chris ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” second quarter 2025 investor letter. The fund underperformed its benchmark, the MSCI World Index (net), in the second ...

The stock's fall snapped a two-day winning streak.

Key Insights The projected fair value for Becton Dickinson is US$341 based on 2 Stage Free Cash Flow to Equity ...

With a market cap of $64 billion, Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) is a global medical technology leader. Operating through three key segments: BD Medical; BD Life ...

Shares of Becton Dickinson & Co. BDX rallied 1.00% to $191.00 Monday, on what proved to be an all-around positive trading ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned -5.78% in the ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, proudly commemorates 65 years of ...

Becton Dickinson CFO Chris DelOrefice will step down Dec. 5 as BD reports strong fiscal 2025 sales and appoints Vitor Roque interim CFO.